KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+18.5%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$342M
AUM Growth
+$342M
Cap. Flow
-$19.6M
Cap. Flow %
-5.73%
Top 10 Hldgs %
99.21%
Holding
12
New
1
Increased
6
Reduced
5
Closed
–

Top Buys

1
ENTA icon
Enanta Pharmaceuticals
ENTA
$1.41M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$1.19M
3
ALKS icon
Alkermes
ALKS
$963K
4
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
$377K
5
NXTC icon
NextCure
NXTC
$330K

Top Sells

1
UTHR icon
United Therapeutics
UTHR
$15.7M
2
ALXN
Alexion Pharmaceuticals Inc
ALXN
$5.05M
3
MCK icon
McKesson
MCK
$3.31M
4
ANAB icon
AnaptysBio
ANAB
$181K
5
REGN icon
Regeneron Pharmaceuticals
REGN
$28K

Sector Composition

1 Healthcare 97.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$56.9M 16.62% 364,274 -32,301 -8% -$5.05M
UTHR icon
2
United Therapeutics
UTHR
$13.8B
$49M 14.3% 322,537 -103,678 -24% -$15.7M
TARO
3
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$40.6M 11.87% 553,646 +16,268 +3% +$1.19M
REGN icon
4
Regeneron Pharmaceuticals
REGN
$61.5B
$39.7M 11.6% 82,200 -58 -0.1% -$28K
ENTA icon
5
Enanta Pharmaceuticals
ENTA
$180M
$36.2M 10.56% 858,811 +33,482 +4% +$1.41M
BIIB icon
6
Biogen
BIIB
$19.4B
$33.8M 9.87% 138,017 +854 +0.6% +$209K
ALKS icon
7
Alkermes
ALKS
$4.78B
$32.3M 9.44% 1,620,675 +48,280 +3% +$963K
MCK icon
8
McKesson
MCK
$85.4B
$29M 8.48% 166,983 -19,047 -10% -$3.31M
SRGA
9
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$14.1M 4.11% 6,423,408 +172,200 +3% +$377K
IVC
10
DELISTED
Invacare Corporation
IVC
$8.1M 2.36% 904,547 +23,627 +3% +$211K
ANAB icon
11
AnaptysBio
ANAB
$569M
$2.38M 0.69% 110,448 -8,410 -7% -$181K
NXTC icon
12
NextCure
NXTC
$13.5M
$330K 0.1% +30,292 New +$330K